T1	Intervention 458 724	ZNS was initiated at a dosage of 100 mg/day and escalated to 200 mg/day at day 14. Patients were evaluated by accelerometry and the Fahn-Tolosa-Marin (FTM) rating scale at baseline and days 14 and 28, as well as the Clinical Global Impression (CGI-C) scale at day 28
T2	Intervention 726 811	At endpoint, subjects assigned to ZNS were taking a mean dosage of 160 +/- 50 mg/day.
